181 related articles for article (PubMed ID: 37477795)
1. PPARγ partial agonist LPSF/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patients.
de Almeida AR; Dantas AT; de Oliveira Gonçalves ME; Chêne C; Jeljeli M; Chouzenoux S; Thomas M; Cunha EGC; de Azevedo Valadares LD; de Melo Gomes JV; de Paula SKS; da Rocha Pitta MG; da Rocha Pitta I; de Melo Rêgo MJB; Pereira MC; Duarte ALBP; Abdalla DSP; Nicco C; Batteux F; da Rocha Pitta MG
Inflammopharmacology; 2024 Feb; 32(1):433-446. PubMed ID: 37477795
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the action of LPSF/GQ-16 on cytokines and PPAR-γ gene expression after in vitro irradiation of peripheral blood mononuclear cells.
Brayner Cavalcanti M; Bezerra Leite LL; Manoel de Queiroz D; de Salazar E Fernandes T; Mendes de Oliveira WL; Pereira MC; da Rocha Pitta MG; de Melo Rêgo MJB; Dos Santos Júnior JA; Herrero Fernández Z; Rodrigues Cravo Teixeira D; Galdino da Rocha Pitta M; da Rocha Pitta I; César Dantas S; Cavalcante Veras R; Almeida de Medeiros I; Borges da Silva E
Int J Radiat Biol; 2021; 97(12):1649-1656. PubMed ID: 34586957
[TBL] [Abstract][Full Text] [Related]
3. IBPA a mutual prodrug of ibuprofen and acetaminophen alleviates inflammation, immune dysregulation and fibrosis in preclinical models of systemic sclerosis.
Rodrigues de Almeida A; Jaime Bezerra Mendonça Junior F; Tavares Dantas A; Eduarda de Oliveira Gonçalves M; Chêne C; Jeljeli M; Chouzenoux S; Thomas M; David de Azevedo Valadares L; Andreza Bezerra Correia M; Ângela da Silva Alves W; Carvalho Lira E; Doridot L; Jesus Barreto de Melo Rêgo M; Cristiny Pereira M; Luzia Branco Pinto Duarte A; Saes Parra Abdalla D; Nicco C; Batteux F; Galdino da Rocha Pitta M
Int Immunopharmacol; 2024 Jul; 136():112344. PubMed ID: 38833846
[TBL] [Abstract][Full Text] [Related]
4. RhoA/Rho-kinase activation promotes lung fibrosis in an animal model of systemic sclerosis.
Bei Y; Hua-Huy T; Nicco C; Duong-Quy S; Le-Dong NN; Tiev KP; Chéreau C; Batteux F; Dinh-Xuan AT
Exp Lung Res; 2016; 42(1):44-55. PubMed ID: 26873329
[TBL] [Abstract][Full Text] [Related]
5. Fibrosis Development in HOCl-Induced Systemic Sclerosis: A Multistage Process Hampered by Mesenchymal Stem Cells.
Maria ATJ; Toupet K; Maumus M; Rozier P; Vozenin MC; Le Quellec A; Jorgensen C; Noël D; Guilpain P
Front Immunol; 2018; 9():2571. PubMed ID: 30455706
[No Abstract] [Full Text] [Related]
6. Chronic LPSF/GQ-02 treatment attenuates inflammation and atherosclerosis development in LDLr
Silva AKSE; Gomes FODS; Santos Silva BD; Ribeiro EL; Oliveira AC; Araújo SMDR; de Lima IT; Oliveira AGV; Rudnicki M; Abdalla DSP; Lima MDCA; Pitta IDR; Peixoto CA
Eur J Pharmacol; 2016 Nov; 791():622-631. PubMed ID: 27693798
[TBL] [Abstract][Full Text] [Related]
7. Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis.
Bagnato G; Bitto A; Irrera N; Pizzino G; Sangari D; Cinquegrani M; Roberts W; Atteritano M; Altavilla D; Squadrito F; Bagnato G; Saitta A
Arthritis Res Ther; 2013 Sep; 15(5):R120. PubMed ID: 24286160
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone inhibits cytokine production in PBMC from systemic sclerosis patients.
de Almeida AR; Dantas AT; Pereira MC; Cordeiro MF; Gonçalves RSG; de Melo Rêgo MJB; da Rocha Pitta I; Duarte ALBP; da Rocha Pitta MG
Inflammopharmacology; 2019 Aug; 27(4):723-730. PubMed ID: 31069604
[TBL] [Abstract][Full Text] [Related]
9. Elevated frequencies of CD4(+) IL-21(+) T, CD4(+) IL-21R(+) T and IL-21(+) Th17 cells, and increased levels of IL-21 in bleomycin-induced mice may be associated with dermal and pulmonary inflammation and fibrosis.
Lei L; He ZY; Zhao C; Sun XJ; Zhong XN
Int J Rheum Dis; 2016 Apr; 19(4):392-404. PubMed ID: 25545680
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of systemic fibrosis in mice by angiotensin II receptor blockade.
Marut W; Kavian N; Servettaz A; Hua-Huy T; Nicco C; Chéreau C; Weill B; Dinh-Xuan AT; Batteux F
Arthritis Rheum; 2013 May; 65(5):1367-77. PubMed ID: 23335130
[TBL] [Abstract][Full Text] [Related]
11. Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models.
Orvain C; Cauvet A; Prudent A; Guignabert C; Thuillet R; Ottaviani M; Tu L; Duhalde F; Nicco C; Batteux F; Avouac J; Wang N; Seaberg MA; Dillon SR; Allanore Y
Arthritis Res Ther; 2022 Jan; 24(1):13. PubMed ID: 34986869
[TBL] [Abstract][Full Text] [Related]
12. New thiazolidinedione LPSF/GQ-2 inhibits NFκB and MAPK activation in LPS-induced acute lung inflammation.
Santos LAMD; Rodrigues GB; Mota FVB; França MER; de Souza Barbosa KP; Oliveira WH; Rocha SWS; Lós DB; Silva AKS; Silva TGD; Peixoto CA
Int Immunopharmacol; 2018 Apr; 57():91-101. PubMed ID: 29475100
[TBL] [Abstract][Full Text] [Related]
13. Baicalein alleviates fibrosis and inflammation in systemic sclerosis by regulating B-cell abnormalities.
Peng B; Hu Q; He R; Hou H; Lian D; Chen Y; Li H; Song L; Gao Y; Chen T; Zhang G; Li J
BMC Complement Med Ther; 2023 Feb; 23(1):62. PubMed ID: 36810081
[TBL] [Abstract][Full Text] [Related]
14. Superiority of systemic bleomycin to intradermal HOCl for the study of interstitial lung disease.
Morozan A; Joy S; Fujii U; Fraser R; Watters K; Martin JG; Colmegna I
Sci Rep; 2023 Nov; 13(1):20577. PubMed ID: 37996447
[TBL] [Abstract][Full Text] [Related]
15. Niclosamide Prevents Systemic Sclerosis in a Reactive Oxygen Species-Induced Mouse Model.
Morin F; Kavian N; Nicco C; Cerles O; Chéreau C; Batteux F
J Immunol; 2016 Oct; 197(8):3018-3028. PubMed ID: 27613696
[TBL] [Abstract][Full Text] [Related]
16. The Fibrosis and Immunological Features of Hypochlorous Acid Induced Mouse Model of Systemic Sclerosis.
Meng M; Tan J; Chen W; Du Q; Xie B; Wang N; Zhu H; Wang K
Front Immunol; 2019; 10():1861. PubMed ID: 31481954
[TBL] [Abstract][Full Text] [Related]
17. iNOS Activity Is Required for the Therapeutic Effect of Mesenchymal Stem Cells in Experimental Systemic Sclerosis.
Maria ATJ; Rozier P; Fonteneau G; Sutra T; Maumus M; Toupet K; Cristol JP; Jorgensen C; Guilpain P; Noël D
Front Immunol; 2018; 9():3056. PubMed ID: 30622540
[No Abstract] [Full Text] [Related]
18. Corticosteroid inhibits chemokines production in systemic sclerosis patients.
Dantas AT; de Almeida AR; Sampaio MCPD; Cordeiro MF; da Rocha LF; de Oliveira PSS; Pereira MC; de Melo Rego MJB; Marques CDL; da Rocha Pitta I; Duarte ALBP; da Rocha Pitta MG
Steroids; 2017 Nov; 127():24-30. PubMed ID: 28866045
[TBL] [Abstract][Full Text] [Related]
19. Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement.
Scala E; Pallotta S; Frezzolini A; Abeni D; Barbieri C; Sampogna F; De Pità O; Puddu P; Paganelli R; Russo G
Clin Exp Immunol; 2004 Dec; 138(3):540-6. PubMed ID: 15544634
[TBL] [Abstract][Full Text] [Related]
20. Different profile of cytokine production in patients with systemic sclerosis and association with clinical manifestations.
Dantas AT; Almeida AR; Sampaio MCPD; Cordeiro MF; Oliveira PSS; Mariz HA; Pereira MC; Rego MJBM; Pitta IDR; Duarte ALBP; Pitta MGDR
Immunol Lett; 2018 Jun; 198():12-16. PubMed ID: 29601941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
